| Disease Name |
Multiple Sclerosis, Relapsing-Remitting |
| Nocoding RNA Name |
hsa-miR-26a |
| Expression Pattern |
down-regulated |
| Species |
Homo sapiens |
| Detection Methods |
Quantitative Real-time PCR,Western Blot,Luciferase Reporter Assay etc. |
| Target |
IL6 |
| Tissue |
blood(lymphocytes) |
| Treatment |
N/A
|
| PubMed ID |
25362566 |
| Year |
2015 |
| Detail Description |
In clinical samples of RRMS patients, it was found that miR26a expression was significantly lower in peripheral blood lymphocytes (PBLs) of patients with RRMS.an IL6-associated miRNA, miR26a, was identified, and its normally downregulated expression was shown to be highly correlated with disease severity in patients suffering from MS as well as in C57BL/6 mice with experimental autoimmune encephalomyelitis (EAE; a well-established animal model of human MS). miR26a was found to downregulate Th17 and to upregulate Treg cell function through its targeting of IL6. |
|